Výsledky vyhledávání - "Rogier R. Press"

Limited Sampling Model for Advanced Mycophenolic Acid Therapeutic Drug Monitoring After Liver Transplantation

Autor: Rogier R. Press, Serge Cremers, Andrzej Baranski, P. Langers, Jan den Hartigh, Bart van Hoek, Akin Inderson

Publikováno v: Therapeutic Drug Monitoring, 36(2), 141-147

The immunosuppressive drug mycophenolate mofetil (MMF), with mycophenolic acid (MPA) as active metabolite, is a nonnephrotoxic alternative to calcineurin inhibitors. Therapeutic drug monitoring (TDM) of MPA may improve clinical benefit from MMF thera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b1958ad212acd7ef1f2cc6e02a39d01
https://doi.org/10.1097/ftd.0b013e3182a37a1e

Zobrazit plný text záznamu

Population Pharmacokinetics and Pharmacogenetics of Everolimus in Renal Transplant Patients

Autor: Henk-Jan Guchelaar, Jan den Hartigh, Dirk Jan A.R. Moes, Tahar van der Straaten, Rogier R. Press, Johan W. de Fijter

Publikováno v: Clinical Pharmacokinetics, 51(7), 467-480

Everolimus is a novel macrolide immunosuppressant used in the prevention of acute and chronic rejection of solid organ transplants. Everolimus is being actively investigated worldwide as a non-nephrotoxic alternative for calcineurin inhibitors. Its h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1950f880039dabda9b00307ccd1439f
https://doi.org/10.2165/11599710-000000000-00000

Zobrazit plný text záznamu

Explaining variability in ciclosporin exposure in adult kidney transplant recipients

Autor: Hans de Fijter, Bart A. Ploeger, Meindert Danhof, T. van der Straaten, Henk-Jan Guchelaar, Hans van Pelt, Jan den Hartigh, Rogier R. Press

Publikováno v: European Journal of Clinical Pharmacology, 66(6), 579-590
European Journal of Clinical Pharmacology

Purpose Optimal ciclosporin A (CsA) exposure in kidney transplant recipients is difficult to attain because of variability in CsA pharmacokinetics. A better understanding of the variability in CsA exposure could be a good means of individualizing the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b74018fcc15b284d8da83f814f07384
https://doi.org/10.1007/s00228-010-0810-9

Zobrazit plný text záznamu

Preemptive Versus Sequential Prophylactic-Preemptive Treatment Regimens for Cytomegalovirus in Renal Transplantation: Comparison of Treatment Failure and Antiviral Resistance

Autor: Martha T. van der Beek, Johan W. de Fijter, Rogier R. Press, Stefan P Berger, Caroline S. van der Blij-de Brouwer, Ann C. T. M. Vossen, Aloys C.M. Kroes, Eric C. J. Claas

Publikováno v: Transplantation. 89:320-326

Background. Cytomegalovirus (CMV) infections after transplantation are commonly treated using a prophylactic or preemptive regimen with (val)ganciclovir. It remains unclear, which approach is most effective in preventing CMV disease in D+R— patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9213994bcbe918659459a6c69621119c
https://doi.org/10.1097/tp.0b013e3181bc0301

Zobrazit plný text záznamu

Minimization of Maintenance Immunosuppression Early After Renal Transplantation

Autor: Frederike J. Bemelman, Ineke J. M. ten Berge, Jaap J. Homan van der Heide, Henrikus J. van Kan, Hans W. de Fijter, Rogier R. Press, Eltjo F. de Maar

Publikováno v: Transplantation, 88(3), 421-428. Lippincott Williams and Wilkins
Transplantation, 88(3), 421-428. LIPPINCOTT WILLIAMS & WILKINS

Introduction. Chronic allograft nephropathy is the main cause of long-term renal transplant failure. Chronic use of calcineurin inhibitors contributes to its pathogenesis. Here, we report on a multicenter randomized trial to study the effects of with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5510e9ac16203ccddbe1e0ed0b0e44d5
https://doi.org/10.1097/tp.0b013e3181af1df6

Zobrazit plný text záznamu

Preoperative predictors of postsurgical adhesion formation and the Prevention of Adhesions with Plasminogen Activator (PAPA-study): results of a clinical pilot study

Autor: Mariette I.E. van Poelgeest, Teake Kooistra, Rogier R. Press, Trudy C.M. Trimbos-Kemper, Wendela Kolkman, Bart W. J. Hellebrekers, Frank Willem Jansen, Lianne S.M. Boesten, J. Baptist Trimbos, Sjef J. Emeis

Publikováno v: Fertility and Sterility. 91:1204-1214

Objective: To identify predictors of postsurgical adhesion formation in peritoneal fluid and plasma, and assess efficacy and safety of reteplase (recombinant plasminogen activator [r-PA]). Design: Prospective randomized study. Setting: University Med

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58e6d9d7aa1c8d10fa10a2d884b5cfb8
https://doi.org/10.1016/j.fertnstert.2008.01.052

Zobrazit plný text záznamu

Exploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipients

Autor: Dirk Jan A R, Moes, Rogier R, Press, Oliver, Ackaert, Bart A, Ploeger, Frederike J, Bemelman, Cheikh, Diack, Judith A M, Wessels, Tahar, van der Straaten, Meindert, Danhof, Jan-Stephan F, Sanders, Jaap J, Homan van der Heide, Henk Jan, Guchelaar, Johan W, de Fijter

Publikováno v: British journal of clinical pharmacology. 82(1)

This study aimed at identifying pharmacological factors such as pharmacogenetics and drug exposure as new predictive biomarkers for delayed graft function (DGF), acute rejection (AR) and/or subclinical rejection (SCR).Adult renal transplant recipient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e7e1cdf37f419944098faaca5ab974fa
https://pubmed.ncbi.nlm.nih.gov/27334415

Zobrazit plný text záznamu

Liquid Chromatography-Tandem Mass Spectrometry Outperforms Fluorescence Polarization Immunoassay in Monitoring Everolimus Therapy in Renal Transplantation

Autor: Johan W. de Fijter, Dirk Jan A.R. Moes, Rogier R. Press, Jan den Hartigh, Henk-Jan Guchelaar

Publikováno v: Therapeutic Drug Monitoring, 32(4), 413-419

Background: There is a need to monitor everolimus blood concentrations in renal transplant recipients as a result of its high pharmacokinetic variability and narrow therapeutic window. However, analytical methods to determine blood concentrations oft

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02f49ca0e38ed08d3f0f15778f707e14
https://hdl.handle.net/1887/111101

Zobrazit plný text záznamu

CsA exposure is associated with acute GVHD and relapse in children after SCT

Autor: R.M. Egeler, J. den Hartigh, J. M. J. J. Vossen, Arjan C. Lankester, Annemieke Willemze, Rogier R. Press

Publikováno v: Bone Marrow Transplantation, 45(6), 1056-1061

CsA is commonly used after haematological SCT (HSCT) as GVHD prophylaxis. In solid organ transplantation, area under the blood concentration vs time curve (AUC) correlates with clinical outcome. However, in HSCT, it has not been determined whether th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fdaa0bc728864220d19460d21b27ce4
https://hdl.handle.net/1887/103802

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání